BOS updateBronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Section snippets
Background
When the original definition of BOS was formulated in 1993, the working group had several goals. The group aimed to provide a classification system for airway disease after lung transplantation that did not rely on histopathologic findings, was sensitive and specific, relied on diagnostic techniques available to all lung transplant physicians, and was relatively simple to understand and apply. The resulting classification system defined post-transplant pulmonary function using the forced
Background
Approximately 2.5% of lung transplant candidates are ≤17 years of age. In terms of the number of transplants, number of patients on the waiting list, and number of active centers, pediatric lung transplantation lags behind adult lung transplantation and other pediatric solid-organ transplantation. Published reports indicate an incidence of BO similar to that of adults,10, 11, 12 except in children <3 years old, in whom it may be lower.10
Airway inspection is particularly important in children to
Background
Many factors have been reported as risk factors for BOS. However, quality of data is often a problem because almost all existing information derives from retrospective studies with no control groups and reflects the experience of single centers. Numbers are small and often difficult to interpret. In some cases, risk factors seem to have been more important in the earlier years of lung transplantation, e.g., cytomegalovirus (CMV) infection. This may reflect a change in the risk environment
Background
Bronchiolitis obliterans is a cicatricial process that affects the small airways of the allograft lung. Conceptually, BO is thought to result from chronic lung rejection, although not exclusively. It progresses through a sequence of lymphohistiocytic-mediated cytotoxicity directed at the respiratory epithelium. The initial process is a lymphocytic infiltrate of the sub-mucosa of the airways with migration of lymphocytes through the basement membrane into the epithelium.57 At this site,
Background
The diagnostic criteria for BOS are based on a decrease in lung function. Various indirect measures or analyses have been undertaken to identify alternative early markers of a decrease in graft performance. Perhaps these markers can provide a surrogate means of predicting disease or of monitoring disease activity, with the aim of enabling early therapy to block a relentless decrease in lung function.
Background
Lung function is exquisitely sensitive to complications that affect the allograft, such as rejection, infection, and anastomotic complications. These complications often produce some degree of airflow obstruction and may lead to a pattern of functional deterioration, which is qualitatively similar to that seen in BOS. In addition, several complications that affect the native lung and disease progression in the native lung may contribute to changing pulmonary function. This section addresses (1)
Recommendations
- 1.
Infection, acute rejection, disease recurrence, and anastomotic complications can confound the diagnosis of BOS. These diagnoses should be excluded or treated before assigning a designation of BOS.
- 2.
Following single lung transplant for emphysema, native lung hyperinflation occasionally results in a functional and physiologic picture similar to BOS. In this setting, a precise diagnosis may be impossible and each case should be judged on its individual characteristics.
- 3.
A number of conditions can
Background
Although the fibrous obliteration of the bronchioles seen in BO probably is irreversible, the histologic lesions are often heterogeneous, with some airways showing inflammatory infiltrates potentially amenable to treatment. This probably explains why some patients show functional stabilization or improvement with treatment. Assessing response to therapy is difficult in individual patients because of the high variability of the disease response of an individual to an intervention.9, 120, 121, 122
Future studies
The committee recognizes that although BOS is the most common complication leading to chronic graft dysfunction and death of lung transplant recipients, it remains poorly understood. However, the course of disease progression may be quite variable for individual patients, suggesting a heterogeneous pathogenesis. Although lung function may decrease rapidly, leading to respiratory failure and death in some patients, other patients may survive for years with either stable or slowly progressive
AppendixFigure 1
Figure 2
References (125)
- et al.
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation
Chest
(1984) - et al.
Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation
J Heart Lung Transplant
(2000) - et al.
Intermediate-term results of heart-lung transplantation for cystic fibrosis
Lancet
(1992) - et al.
Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation
Chest
(1995) - et al.
Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
J Thorac Cardiovasc Surg
(1997) - et al.
Transforming growth factor-beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation
J Heart Lung Transplant
(1999) - et al.
Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients
Chest
(1996) - et al.
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome
J Thorac Cardiovasc Surg
(1998) - et al.
Treatment of respiratory syncytial viral and parainfluenza lower respiratory tract infections in lung transplant patients
J Heart Lung Transplant
(2001) - et al.
The Registry of the International Society for Heart and Lung Transplantationseventeenth official report—2000
J Heart Lung Transplant
(2000)
Immunological monitoring of lung transplant patients by bronchoalveolar analysis
Transplant Rev
Effects of donor bone marrow infusion in clinical lung transplantation
Ann Thorac Surg
Cytokine gene polymorphisms and relevance to forms of rejection
Transplant Proc
Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations
J Heart Lung Transplant
Importance of chronic aspiration in recipients of heart-lung transplants
Lancet
Impaired gastrointestinal motility in pulmonary transplantation
Lancet
Upper gastrointestinal dysmotility in heart-lung transplant recipients
Ann Thorac Surg
Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant
Chest
Bronchiolitis obliterans after lung transplantationdetection using expiratory HRCT
Chest
Bronchial responsiveness after human heart-lung transplantation
Chest
Bronchial responsiveness to exercise after human cardiopulmonary transplantation
Chest
Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients
Chest
Unilateral auto-PEEP in the recipient of a single-lung transplant
Chest
Obliterative bronchiolitis after heart-lung transplantationapparent arrest by augmented immunosuppression
Ann Intern Med
A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allograftsInternational Society for Heart and Lung Transplantation
J Heart Lung Transplant
Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantationa comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second
J Heart Lung Transplant
Detection of obliterative bronchiolitis after lung transplantation by indexes of ventilation distribution
Am J Respir Crit Care Med
Early detection of airway involvement in obliterative bronchiolitis after lung transplantationFunctional and bronchoalveolar cell findings
Am J Respir Crit Care Med
Spirometry values in stable lung transplant recipients
Am J Respir Crit Care Med
Standardization of spirometry1994 update
Am Rev Respir Dis
Pediatric lung transplantation at St. Louis Children’s Hospital, 1990–1995
Am J Respir Crit Care Med
Heart-lung transplantation for patients under 10 with cystic fibrosis
Arch Dis Child
Forced expiratory flows and volumes in infantsNormative data and lung growth
Am J Respir Crit Care Med
Flow limitation in infants assessed by negative expiratory pressure
Am J Respir Crit Care Med
Growth of lungs after transplantation in infants and in children younger than 3 years old
Am J Resp Crit Care Med
Obliterative bronchiolitis after lung and heart-lung transplantationAn analysis of risk factors and management
J Thorac Cardiovasc Surg
Risk factors for the development of obliterative bronchiolitis after lung transplantation
J Heart Lung Transplant
Bronchiolitis obliterans syndromeincidence, natural history, prognosis, and risk factors
J Heart Lung Transplant
Analysis of risk factors for the development of bronchiolitis obliterans syndrome
Am J Respir Crit Care Med
Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation—early risk factors
Transplantation
Treatment of presumed and proven acute rejection following six months of lung transplant survival
Am J Respir Crit Care Med
Refractoriness of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts
J Heart Lung Transplant
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation
Ann Thorac Surg
Noncompliance in organ transplant recipients
Transplantation
Renal transplant patient compliance with free immunosuppressive medications
Transplantation
Incidence, determinants and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients
Transplantation
Medication compliance following renal transplantation
Transplantation
Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation
Transplantation
Lung transplantation bronchiolitis obliterans
Cytomegalovirus infection and pneumonitisImpact after isolated lung transplantation. Washington University Lung Transplant Group
Am Rev Respir Dis
Cited by (1168)
Chronic lung allograft dysfunction in 2022, past and updates
2023, Revue des Maladies RespiratoiresHistory of Lung Transplantation
2023, Clinics in Chest MedicineAcute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction
2023, Clinics in Chest MedicineBronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer
2023, Respiratory Medicine Case ReportsRemote ex vivo lung perfusion at a centralized evaluation facility
2022, Journal of Heart and Lung TransplantationRisk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation
2022, Journal of Heart and Lung Transplantation